Search - tctmd.com

Displaying 1 - 20 of 46

Sort: Relevancy | Date

News Daily News

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Caitlin E. Cox

November 30, 2017

News Conference News TCT 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

EVOLUT R Procedural Pearls (Including how NOT to Need a New Pacemaker)

Presenter: Hemal Gada

October 31, 2017

Presentation TCT 2017

EVOLUT R TAVR Technology Review (Including EVOLUT 34mm and PRO) and Clinical Program Updates

Presenter: John K. Forrest

October 31, 2017

Presentation TCT 2017

The Evolut R Low-risk Trial

Presenter: Jeffrey J. Popma

October 30, 2017

Presentation TCT 2017

Malposition of the Evolut R Bioprosthesis During TAVR

Presenter: Mohamed Ahmed Sobhy, Tomasz Gasior

October 30, 2017

News Opinion Off Script TCT 2017

Off Script: Welcome to TCT 2017 in the Mile High City

Kwan S. Lee

October 29, 2017

News Daily News

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

Caitlin E. Cox

October 18, 2017

News Conference News PCR London Valves 2017

CT Scans Before and After TAVR Show Tricuspid, Bicuspid Valves Are Reassuringly Similar

Shelley Wood

September 28, 2017

News Daily News

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Michael O'Riordan

September 27, 2017

News Conference News PCR London Valves 2017

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Shelley Wood

September 27, 2017

News Daily News

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

Yael L. Maxwell

September 15, 2017

News Industry News

Micro Interventional Devices, Inc.™ Completes First Clinical Tricuspid Bicuspidization Procedure Utilizing MIA™ Technology

September 07, 2017

News Industry News

Medtronic Announces CE Mark and European Launch of CoreValve(TM) Evolut(TM) PRO Transcatheter Valve with Advanced Sealing

August 01, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2017

Shelley Wood

July 31, 2017

News Daily News

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

Michael O'Riordan

July 10, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Conference News TVT 2017

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Shelley Wood

June 19, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

Advertisement

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

EVOLUT R Procedural Pearls (Including how NOT to Need a New Pacemaker)

EVOLUT R TAVR Technology Review (Including EVOLUT 34mm and PRO) and Clinical Program Updates

The Evolut R Low-risk Trial

Malposition of the Evolut R Bioprosthesis During TAVR

Off Script: Welcome to TCT 2017 in the Mile High City

Severe Aortic Stenosis Gets Its Own Appropriate Use Criteria

CT Scans Before and After TAVR Show Tricuspid, Bicuspid Valves Are Reassuringly Similar

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

Micro Interventional Devices, Inc.™ Completes First Clinical Tricuspid Bicuspidization Procedure Utilizing MIA™ Technology

Medtronic Announces CE Mark and European Launch of CoreValve(TM) Evolut(TM) PRO Transcatheter Valve with Advanced Sealing

TCTMD’s Top 10 Most Popular Stories for July 2017

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content